Dudediligence.

Grace Therapeutics, Inc

GRCENASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$3.4MSep ’24−$4.2MDec ’24$636,000Mar ’25−$3.4MJun ’25−$938,000Sep ’25−$2.3MDec ’25−$1.2MMar ’26−$15.8MJun ’26
Fiscal years, by the month each ended
LineMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue$0.00none on filenone on filenone on filenone on file
Gross profit$0.00none on filenone on filenone on filenone on file
Operating income−$15.6M−$52.2M−$12.9M−$16.7M−$11.1M
Net income−$9.8M−$42.4M−$12.9M−$9.6M−$7.8M
Operating cash flow−$17.2M−$15.9M−$12.3M−$14.9M−$8.9M
Cash$30.3M$27.9M$23.0M$22.1M$17.0M
Shares outstanding44.3M7.4M9.4M13.7M16.0M